UPDATE 1-Athersys stem-cell therapy for bowel disease fails in trial – Reuters
|
UPDATE 1-Athersys stem–cell therapy for bowel disease fails in trial
Reuters The stem–cell therapy, known as MultiStem, is derived from adult bone marrow or other tissue sources and is designed to reduce inflammation and protect and heal damaged tissue. MultiStem was being tested in patients with ulcerative colitis who have … Athersys Inc. stem cell therapy for bowel disease fails to show ‘meaningful …Crain’s Cleveland Business Athersys Announces Results From Phase 2 Study of MultiStem(R) Cell Therapy …Wall Street Journal Athersys Issues Phase 2 Study Results of Multistem Cell Therapy for UC, Failed …Benzinga |
